Share on LinkedInShare on LinkedIn

ARTICLE · 21 DECEMBER 2021

PTAB News: First Arthrex Director Review Granted

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

In a recent decision, Commissioner Andrew Hirschfeld, who is currently performing the functions and duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO...

United StatesIntellectual Property

In a recent decision, Commissioner Andrew Hirschfeld, who is currently performing the functions and duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO, issued the first post-Arthrex grant of Director review. Prior to this decision, all requests for Director review have been denied.

As discussed in previous posts, the Supreme Court held in Arthrex that the USPTO Director has discretion to review PTAB final written decisions. Soon after that decision, the USPTO implemented an interim procedure by which a party to a PTAB proceeding could request review of final written decisions in an inter partes, post-grant, or covered business method review. The first decisions on requests were issued in early July 2021, with all prior requests being denied.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from